Yvonne L. Eaglehouse
- Pharmacy top 10%
-
- Global Cancer Incidence and Screening 15
- Cancer Risks and Factors 3
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
-
- Physical Activity and Health 5
-
- Economic and Financial Impacts of Cancer 15
- Health Systems, Economic Evaluations, Quality of Life 5
-
- Obesity, Physical Activity, Diet 5
-
- Health and Lifestyle Studies 4
- Co-authors
- Craig D. ShriverKangmin ZhuMatthew W. GeorgM. Kaye KramerAndrea M. KriskaVincent C. ArenaRachel G. MillerKarl K. Vanderwood
- Journals
- Journal of Clinical Oncology (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Medicine & Science in Sports & Exercise (1 paper)
- Partner nations
- United StatesNorwaySingapore
In The Last Decade
Yvonne L. Eaglehouse
34 papers receiving 430 citations
Peers
Comparison fields: 5 of 73
- Pharmacy 39
- Oncology 168
- Endocrinology, Diabetes and Metabolism 70
- Cancer Research 52
- Physiology 79
Countries citing papers authored by Yvonne L. Eaglehouse
This map shows the geographic impact of Yvonne L. Eaglehouse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvonne L. Eaglehouse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvonne L. Eaglehouse more than expected).
Fields of papers citing papers by Yvonne L. Eaglehouse
This network shows the impact of papers produced by Yvonne L. Eaglehouse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvonne L. Eaglehouse. The network helps show where Yvonne L. Eaglehouse may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yvonne L. Eaglehouse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 17 | |
| 10 | 2019 | 9 | |
| 11 | 2019 | 36 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 3 | |
| 15 | 2018 | 3 | |
| 16 | 2018 | 12 | |
| 17 | 2017 | 15 | |
| 18 | 2016 | 35 | |
| 19 | 2015 | 61 | |
| 20 | 2015 | 13 |
About Yvonne L. Eaglehouse
Yvonne L. Eaglehouse is a scholar working on Oncology, Pharmacy and Economics and Econometrics, having authored 36 papers that have together received 435 indexed citations. Recurring topics across this work include Global Cancer Incidence and Screening (15 papers), Economic and Financial Impacts of Cancer (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Obesity, Physical Activity, Diet (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Physical Activity and Health (5 papers), Health and Lifestyle Studies (4 papers) and Cancer Risks and Factors (3 papers). The work is most often cited by research in Pharmacy (39 citations), Oncology (168 citations) and Endocrinology, Diabetes and Metabolism (70 citations). Yvonne L. Eaglehouse has collaborated with scholars based in United States, Norway and Singapore. Frequent co-authors include Craig D. Shriver, Kangmin Zhu, Matthew W. Georg, M. Kaye Kramer, Andrea M. Kriska, Vincent C. Arena, Rachel G. Miller, Karl K. Vanderwood, Elizabeth M. Venditti and Yue‐Fang Chang. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Medicine & Science in Sports & Exercise.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.